Prentiss Smith & CO Inc Imv Inc. Transaction History

Prentiss Smith & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	BUY	$2.12 - $3.24 $42,400 - $64,800	20,000 Added 85.2%	43,474 $95,000
Q4 2018 Jan 15, 2019	SELL	$4.93 - $6.34 $103,037 - $132,506	-20,900 Reduced 47.1%	23,474 $121,000
Q3 2018 Oct 23, 2018	BUY	$4.65 - $5.94 $196,169 - $250,590	42,187 Added 1928.99%	44,374 $264,000
Q2 2018 Jul 19, 2018	BUY	$4.42 - $7.13 $9,666 - $15,593	2,187 New	2,187 $11,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Prentiss Smith & CO Inc with notifications on news.